Monday, 21 November 2016

FDA approves Novo Nordisk's diabetes drug

(Reuters) - Novo Nordisk A/S said the U.S. Food and Drug Administration approved on Monday its diabetes drug, Xultophy.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)